NLS Pharmaceutics | We design affordable, safe and effective drugs to safeguard and empower the brain throughout all stages of life. Our aim is to improve quality of life and longevity. We are creating new approaches to treat mental and behavioral disorders, and to enhance cognitive function in healthy people.

Welcome to NLS Pharmaceutics

Sep 30, 2019
NLS Pharmaceutics Ltd. Announces Notice of Allowance of a new U.S. Patent Covering Attention Deficit Hyperactivity Disorder strengthening the scope of NLS’ Patent Portfolio.
Aug 13, 2019
NLS Pharmaceutics Ltd. (NLS) Announces a Reexamination Certificate by the USPTO Further Strengthening their ADHD Use Patent Validity
Jul 3, 2019
NLS Pharmaceutics Ltd. (NLS) Announces Notice of Allowance of two new Patents in North America Covering Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy further bolstering its Patent Portfolio
Mar 19, 2019
NLS Pharmaceutics Announces the Completion of the Merger between NLS Pharma Ltd., NLS- 1 Pharma Ltd. and NLS-0 Pharma, Unifying the Global Operations and Development of Nolazol®